发明名称 Methods and products for treating proliferative diseases
摘要 Methods and products for treating proliferative diseases, and wounds, using as a pharmacon an autophagy inhibitor, a glycolytic inhibitor, and/or an agent able to alter cellular production of reactive oxygen, or combination thereof, optionally in combination with one or more chemotherapeutic agents. In some embodiments, the invention combines a 4-aminoquinoline, exemplified by chloroquine, with a glycolytic inhibitor, exemplified by 2-deoxy-D-glucose and anti-VEGF antibodies. The systems and methods of the invention may be used to treat drug-resistant or multi-drug resistant cancers.
申请公布号 US9073985(B2) 申请公布日期 2015.07.07
申请号 US200913054147 申请日期 2009.07.14
申请人 The Regents of the University of Colorado, a body corporate 发明人 Newell Martha Karen;Rogers Susannah K.
分类号 C07K16/22;A61K31/4409;A61K31/7004;A61K39/395;A61K45/06;A61K31/4706;A61K39/00 主分类号 C07K16/22
代理机构 Wolf, Greenfield & Sacks, P.C. 代理人 Wolf, Greenfield & Sacks, P.C.
主权项 1. A method for treating cancer, comprising: administering to a subject a therapeutically acceptable amount of an autophagy inhibitor and a VEGF receptor antagonist in an effective amount to treat the cancer, wherein the VEGF receptor antagonist is a small molecule inhibitor of a VEGFR tyrosine kinase and the autophagy inhibitor is chloroquine, and wherein the autophagy inhibitor and the VEGF receptor antagonist are administered sequentially.
地址 Denver CO US